Healio

FDA issues warning against using epinephrine nasal solutions from BPI Labs, Endo USA

Please provide your email address to receive an email when new articles are posted on . The FDA has advised health care professionals that they should not use unapproved epinephrine nasal solutions ...
Monthly Prescribing Reference

FDA Warns Clinicians Not to Confuse Epinephrine Products Due to Similar Packaging

Epinephrine nasal solutions from BPI Labs and Endo USA should not be used, according to the FDA. Similarities between the packaging for certain intranasal and intravenous epinephrine products may ...
WFTV

Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine Nasal Solution, USP) Due to the Potential for Administration Errors

Endo, Inc (OTCQX: NDOI) (“Endo”), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling all lots within expiry of Adrenalin® Chloride Solution (EPINEPHrine ...
Seeking Alpha

Aquestive Therapeutics: Anaphylm Could Gain Significant Market Share

Aquestive Therapeutics' Anaphylm offers a unique, non-injectable epinephrine solution for anaphylaxis, with NDA decision expected imminently. Anaphylm's advantages—wallet portability, rapid onset, and ...
Business Wire

TD Solutions Announces Epi Mist™ HypoSpray® Epinephrine

PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--TD Solutions announced today that they have initiated development of Epi Mist™ HypoSpray Epinephrine for allergic reactions. More than 35 million Americans ...